ABSTRACT. Diffuse mesangial sclerosis (DMS) is one of the hereditary glomerular diseases and histologically characterized by severe glomerulosclerosis and subsequent tubulo-interstitial fibrosis (TIF). In DMS patients, renal dysfunction correlates well with TIF, rather than with glomerular lesions. Thus, molecular mechanisms whereby TIF in DMS progresses should be addressed. Previously, we found that nephrotic ICGN mice manifest DMS-like lesions and develop renal dysfunction in accordance with onset of TIF. In the present study, we investigated fibrogenic events involved in the progression of TIF after DMS manifestation, using the DMS mouse model. Immunohistochemistry revealed that expression of transforming growth factor-beta (TGF-β) was rare in the interstitial cells of the nephrotic mice at the early-stage of DMS, while the TGF-β expression became evident in the late-stage DMS mice. Platelet-derived growth factor (PDGF) was mildly expressed in the distal tubules of the early-stage DMS mice, whereas the PDGF expression markedly increased at the late-stage of DMS. As a result, α-actin-positive myofibroblastic cells were found dominant in the interstitial spaces of the latestage DMS mice. Finally, TIF became severe in accordance with the overexpressions of these molecules. Our results suggest that in our murine model: 1) persistent proteinuria leads to over-expression of TGF-β and PDGF in non-glomerular areas; 2) these cytokines provoke interstitial myofibroblast accumulation; and 3) the myofibroblasts produce fibrotic matrix proteins in the interstitial spaces. This process may possibly contribute to the development of TIF in DMS patients.KEY WORDS: diffuse mesangial sclerosis, growth factor, ICGN mouse, myofibroblast, tubulo-interstitial fibrosis.J. Vet. Med. Sci. 63(3): 299-307, 2001 Renal dysfunction has been, in numerous chronic renal diseases, characterized by a progressive loss in glomerular filtration ratio. In some cases, glomerular injury could be a crucial determinant for progression of a loss in renal function [7]. During the past several years, much interest focused on investigating molecular basis of glomerulosclerosis [16,35,41]. In contrast, decline in renal function correlates, in most patients with chronic kidney disease, more closely with extents of tubular and interstitial lesions than with that of the glomerular injury [4,29,38]. Therefore, recent attention is now being paid to the molecular basis of tubulo-interstitial lesions [9,17,33,43].In intractable nephrotic syndrome (NS), patients exhibit glomerular sclerotic injury and massive proteinuria, leading to renal failure [19]. Indeed, the glomerular damage may be responsible for clinical manifestation of proteinuria, but tubular and tubulo-interstitial lesions rather than the glomerular injury seem to be a reliable histological marker for predicting prognosis of the patients [3,42]. Until now, molecular basis of tubulo-interstitial fibrosis (TIF) has been investigated in some NS models with or without glomerular injury [9].Glomeruloscle...